Evidence map›Paper›PMID 41246352›Full record

ArticleFrontiers in immunology2025

Case Report: Novel

Yushiro Endo, Tomohiro Koga, Shota Kurushima, Takuya Tomokawa, Hiroyuki Mishima, Koh-Ichiro Yoshiura, Tadashi Matsumoto, Atsushi Kawakami

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yushiro EndoDepartment of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Medical Sciences, Nagasaki, Japan.
Tomohiro KogaDepartment of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Medical Sciences, Nagasaki, Japan.
Shota KurushimaDepartment of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Medical Sciences, Nagasaki, Japan.
Takuya TomokawaDepartment of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Medical Sciences, Nagasaki, Japan.
Hiroyuki MishimaDepartment of Human Genetics, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
Koh-Ichiro YoshiuraDepartment of Human Genetics, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
Tadashi MatsumotoDepartment of Human Genetics, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Atsushi KawakamiDepartment of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Medical Sciences, Nagasaki, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interferon regulatory factor 2 binding protein 2 (IRF2BP2) is a transcriptional corepressor involved in immune regulation via IRF1-mediated interferon signaling inhibition. Pathogenic

Indexed as

B-LymphocytesCell DifferentiationRepressor ProteinsTh1 CellsDNA-Binding ProteinsEast Asian PeopleFemaleHumansMiddle AgedMutation, MissenseTranscription FactorsDNA-Binding ProteinsIRF2BP2 protein, humanRepressor ProteinsTranscription FactorsB-cell differentiationcommon variable immunodeficiency disorder (CVID)IRF2BP2 variantSTAT1 signalingTh1 polarization

Identifiers

PMID41246352
PMCPMC12611837

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.